Curt I. Civin

Q: What Schools Are Affiliated With Curt I. Civin

Curt I. Civin is affiliated with the following schools: University of Maryland, College Park, University of Alabama, Amherst College, University System of Maryland, Johns Hopkins University, Duke University

Curt I. Civin's AcademicInfluence.com Rankings

Curt I. Civin

Medical

#2930

World Rank

#3376

Historical Rank

Oncology

#197

World Rank

#203

Historical Rank

medical Degrees

Download Badge

Medical

Curt I. Civin's Degrees

Bachelors Chemistry Johns Hopkins University

Why Is Curt I. Civin Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Curt I. Civin's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. (1986) (1096)
Characterization of clonogenic multiple myeloma cells. (2004) (805)
The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB–binding protein (1996) (743)
CD34+ hematopoietic stem-progenitor cell microRNA expression and function: A circuit diagram of differentiation control (2006) (504)
Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. (1987) (477)
Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. (1997) (472)
A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. (1992) (425)
Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development. (2005) (383)
Mobile Interspersed Repeats Are Major Structural Variants in the Human Genome (2010) (251)
Antigenic analysis of hematopoiesis. VI. Flow cytometric characterization of My-10-positive progenitor cells in normal human bone marrow. (1987) (232)
Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells. (1990) (227)
Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow stem cells in vivo. (1996) (225)
Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin. (1987) (223)
Notch inhibits Ptf1 function and acinar cell differentiation in developing mouse and zebrafish pancreas (2004) (223)
Flow cytometric analysis of human bone marrow: I. Normal erythroid development (1987) (202)
Levels of p53 protein increase with maturation in human hematopoietic cells. (1991) (201)
Flow cytometric analysis of human bone marrow: I. Normal erythroid development. (1987) (199)
Antigenic analysis of hematopoiesis. V. Characterization of My-10 antigen expression by normal lymphohematopoietic progenitor cells. (1986) (198)
Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem‐cell glycoprotein CD34 (My 10) (1990) (193)
Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice. (2003) (191)
Life-threatening airway obstruction as a complication to the management of mediastinal masses in children. (1985) (181)
Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000 (2005) (170)
The estrogen receptor CpG island is methylated in most hematopoietic neoplasms. (1996) (169)
Highly purified CD34-positive cells reconstitute hematopoiesis. (1996) (163)
Carrier detection in X-linked agammaglobulinemia by analysis of X-chromosome inactivation. (1987) (160)
Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells. (2003) (159)
My-1, New Myeloid-Specific Antigen Identified by a Mouse Monoclonal Antibody (1981) (158)
Flow cytometric analysis of human bone marrow. IV. Differential quantitative expression of T-200 common leukocyte antigen during normal hemopoiesis. (1988) (150)
Kruppel-Like Factor 4 Is Essential for Inflammatory Monocyte Differentiation In Vivo1 (2008) (141)
Microarray and Serial Analysis of Gene Expression Analyses Identify Known and Novel Transcripts Overexpressed in Hematopoietic Stem Cells (2004) (135)
Antigenic analysis of hematopoiesis: a review. (1993) (133)
Asynchronous Antigen Expression in B Lineage Acute Lymphoblastic Leukemia (1988) (128)
Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile. (2013) (128)
Single cell origin of multilineage colonies in culture. Evidence that differentiation of multipotent progenitors and restriction of proliferative potential of monopotent progenitors are stochastic processes. (1984) (122)
Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype (1991) (121)
Cell surface antigens on human marrow cells: dissection of hematopoietic development using monoclonal antibodies and multiparameter flow cytometry. (1987) (116)
HES1 Inhibits Cycling of Hematopoietic Progenitor Cells via DNA Binding (2006) (115)
Clinicopathologic and cytogenic features of CD34 (My 10)-positive acute nonlymphocytic leukemia. (1989) (114)
Notch signaling activation in human embryonic stem cells is required for embryonic, but not trophoblastic, lineage commitment. (2008) (110)
TEL-AML1, expressed from t(12;21) in human acute lymphocytic leukemia, induces acute leukemia in mice. (2002) (107)
Nuclear oncoprotein expression as a function of lineage, differentiation stage, and proliferative status of normal human hematopoietic cells. (1989) (107)
Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells (1990) (106)
Full-length but not truncated CD34 inhibits hematopoietic cell differentiation of M1 cells. (1995) (103)
The t(1;22) (p13;q13) Is Nonrandom and Restricted to Infants With Acute Megakaryoblastic Leukemia: A Pediatric Oncology Group Study (1991) (103)
Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study. (1989) (103)
Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: a Pediatric Oncology Group study. (1990) (99)
Human monomyeloid cell membrane antigens. (1990) (99)
Normal human bone marrow precursors that express terminal deoxynucleotidyl transferase include T-cell precursors and possible lymphoid stem cells. (1991) (97)
The presence within single K-562 cells of erythropoietic and granulopoietic differentiation markers (1981) (94)
FLT3-ITD knockin impairs hematopoietic stem cell quiescence/homeostasis, leading to myeloproliferative neoplasm. (2012) (92)
Target cells for granulocyte colony-stimulating factor, interleukin-3, and interleukin-5 in differentiation pathways of neutrophils and eosinophils. (1990) (91)
Ex vivo culture with human brain endothelial cells increases the SCID-repopulating capacity of adult human bone marrow. (2002) (87)
High-dose cytarabine for intensification of early therapy of childhood acute myeloid leukemia: a Pediatric Oncology Group study. (1991) (87)
Monoclonal antibody localization of A and B isoantigens in normal and malignant fixed human tissues. (1984) (86)
Acute leukemia expressing the normal human hematopoietic stem cell membrane glycoprotein CD34 (MY10). (1988) (82)
Improved methods for the generation of human gene knockout and knockin cell lines (2005) (82)
C/EBPα directs monocytic commitment of primary myeloid progenitors (2006) (81)
Positive stem cell selection--basic science. (1990) (80)
Localization of hematopoietic progenitor cells in tissue with the anti-My-10 monoclonal antibody. (1985) (76)
Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood. (2002) (75)
Kruppel-Like Factor 4 Is Essential for Inflammatory Monocyte Differentiation In Vivo. (2007) (71)
Disparate differentiation in hemopoietic colonies derived from human paired progenitors. (1985) (71)
Expression of myeloid-associated and lymphoid-associated cell-surface antigens in acute myeloid leukemia of childhood: a Pediatric Oncology Group study. (1992) (69)
Flt3high and Flt3low CD34+Progenitor Cells Isolated From Human Bone Marrow Are Functionally Distinct (1998) (68)
Up-regulation of surface CD34 is associated with protein kinase C-mediated hyperphosphorylation of CD34. (1992) (67)
Third-generation, self-inactivating gp91(phox) lentivector corrects the oxidase defect in NOD/SCID mouse-repopulating peripheral blood-mobilized CD34+ cells from patients with X-linked chronic granulomatous disease. (2002) (65)
Activated protein kinase C directly phosphorylates the CD34 antigen on hematopoietic cells. (1990) (62)
Immunotherapy of established tumors using bone marrow transplantation with antigen gene–modified hematopoietic stem cells (2003) (61)
High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias (2010) (61)
Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells (2017) (59)
Acute neurotoxicity after intrathecal cytosine arabinoside in two adolescents with acute lymphoblastic leukemia of B‐cell type (1993) (59)
Human CD34+ cell preparations contain over 100-fold greater NOD/SCID mouse engrafting capacity than do CD34- cell preparations. (2001) (59)
MiR-27a Functions as a Tumor Suppressor in Acute Leukemia by Regulating 14-3-3θ (2012) (57)
Flt3high and Flt3low CD34+ progenitor cells isolated from human bone marrow are functionally distinct. (1998) (56)
Flow cytometric analysis of normal B lymphoid development. (1988) (55)
Mature human hematopoietic cells in donor bone marrow complicate interpretation of stem/progenitor cell assays in xenogeneic hematopoietic chimeras. (1998) (55)
c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase–Activated Leukemias (2015) (55)
Interleukin-6 directly impairs the erythroid development of human TF-1 erythroleukemic cells. (2014) (55)
Asynchronous antigen expression in B lineage acute lymphoblastic leukemia. (1988) (54)
The t(1;22) (p13;q13) is nonrandom and restricted to infants with acute megakaryoblastic leukemia: a Pediatric Oncology Group Study. (1991) (54)
Fas Ligand as a Tool for Immunosuppression and Generation of Immune Tolerance (2004) (54)
Further characterization of immunological unresponsiveness induced in mice by ultraviolet radiation. Growth and induction of nonultraviolet-induced tumors in ultraviolet-irradiated mice. (1979) (53)
Antigenic analysis of hematopoiesis. I. Expression of the My-1 granulocyte surface antigen on human marrow cells and leukemic cell lines. (1983) (51)
The action of bryostatin on normal human hematopoietic progenitors is mediated by accessory cell release of growth factors. (1990) (50)
Selection of Normal Human Hematopoietic Stem Cells for Bone Marrow Transplantation Using Immunomagnetic Microspheres and CD34 Antibody (1991) (49)
RAS gene mutations in childhood acute myeloid leukemia: A pediatric oncology group study (1990) (49)
High Levels of Transgene Expression Following Transduction of Long‐Term NOD/SCID‐Repopulating Human Cells with a Modified Lentiviral Vector (2001) (49)
In vivo engraftment potential of clinical hematopoietic grafts. (1998) (48)
Cutting Edge: The Transcription Factor Kruppel-Like Factor 4 Regulates the Differentiation of Th17 Cells Independently of RORγt (2010) (48)
Activating Signals Dominate Inhibitory Signals in CD137L/IL-15 Activated Natural Killer Cells (2011) (48)
Flow cytometric detection of rare normal human marrow cells with immunophenotypes characteristic of acute lymphoblastic leukemia cells. (1992) (46)
C/EBPalpha directs monocytic commitment of primary myeloid progenitors. (2006) (46)
A comparison of induction and maintenance therapy for acute nonlymphocytic leukemia in childhood: results of a Pediatric Oncology Group study. (1991) (46)
Biology of CD34+CD38- cells in lymphohematopoiesis. (1998) (45)
Generation and genetic engineering of human induced pluripotent stem cells using designed zinc finger nucleases. (2013) (44)
Steel factor supports the cycling of isolated human CD34+ cells in the absence of other growth factors. (1995) (43)
Transduction of donor hematopoietic stem-progenitor cells with Fas ligand enhanced short-term engraftment in a murine model of allogeneic bone marrow transplantation. (2002) (43)
Late stage erythroid precursor production is impaired in mice with chronic inflammation (2012) (43)
Pluripotent Stem Cell–Based Cancer Therapy: Promise and Challenges (2012) (42)
Targeted manipulation of mammalian genomes using designed zinc finger nucleases. (2009) (41)
Eight lipooligosaccharides of Neisseria meningitidis react with a monoclonal antibody which binds lacto-N-neotetraose (Gal beta 1-4GlcNAc beta 1-3Gal beta 1-4Glc) (1991) (41)
Measurement of CD34+ cells in bone marrow by flow cytometry. (1993) (40)
Glycolipid antigen expression in human lung cancer. (1986) (39)
Anti-My-28, an antigranulocyte mouse monoclonal antibody, binds to a sugar sequence in lacto-N-neotetraose. (1985) (39)
CBFβ-SMMHC, Expressed in M4eo Acute Myeloid Leukemia, Reduces p53 Induction and Slows Apoptosis in Hematopoietic Cells Exposed to DNA-Damaging Agents (1998) (38)
The adapter protein CrkL associates with CD34. (2001) (38)
Expression of protooncogene c-myb in normal human hematopoietic cells (1989) (38)
Ex vivo culture of cord blood CD34+ cells expands progenitor cell numbers, preserves engraftment capacity in nonobese diabetic/severe combined immunodeficient mice, and enhances retroviral transduction efficiency. (1999) (37)
Assessment of proliferation during maturation of the B lymphoid lineage in normal human bone marrow. (1988) (36)
Altered cytoplasmic/nuclear distribution of the c-myc protein in differentiating ML-1 human myeloid leukemia cells. (1993) (36)
CD antigens 2002. (2002) (35)
Quantity and quality of engrafting cells in cord blood and autologous mobilized peripheral blood. (1999) (34)
Coordinate glycosylation and cell surface expression of glycophorin A during normal human erythropoiesis (1987) (34)
Artemisinin-derived dimer phosphate esters as potent anti-cytomegalovirus (anti-CMV) and anti-cancer agents: a structure-activity study. (2013) (32)
Expression of protooncogene c-myb in normal human hematopoietic cells. (1989) (30)
Acceleration of G(1) cooperates with core binding factor beta-smooth muscle myosin heavy chain to induce acute leukemia in mice. (2002) (30)
MicroRNAs as regulators and effectors of hematopoietic transcription factors (2019) (28)
Detection of a circulating gastrointestinal cancer antigen in sera of patients with gastrointestinal malignancies by a double determinant immunoassay with monoclonal antibodies against human blood group determinants. (1984) (28)
Regulation of RAB5C Is Important for the Growth Inhibitory Effects of MiR-509 in Human Precursor-B Acute Lymphoblastic Leukemia (2014) (28)
Increased risk of lethal graft-versus-host disease-like syndrome after transplantation into NOD/SCID mice of human mobilized peripheral blood stem cells, as compared to bone marrow or cord blood. (2002) (27)
Mice deficient in MIM expression are predisposed to lymphomagenesis (2012) (27)
Selective Reduction of Graft-versus-Host Disease-Mediating Human T Cells by Ex Vivo Treatment with Soluble Fas Ligand1 (2009) (26)
Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs (2016) (26)
CD antigens 2001 (2001) (25)
Detection of minimal residual T cell acute lymphoblastic leukemia by flow cytometry. (1990) (25)
Deletion of Tristetraprolin Caused Spontaneous Reactive Granulopoiesis by a Non–Cell-Autonomous Mechanism Without Disturbing Long-Term Hematopoietic Stem Cell Quiescence (2011) (25)
Flt 3 high and Flt 3 low CD 34 1 Progenitor Cells Isolated From Human Bone Marrow Are Functionally Distinct (1998) (25)
Autologous bone marrow transplantation in T-cell malignancies: A case report involving in vitro treatment of marrow with a pan-T-cell monoclonal antibody (1982) (24)
Rapid, efficient cloning of murine hybridoma cells in low gelation temperature agarose. (1983) (24)
Treatment of poor prognosis non-Hodgkin's lymphoma using cyclophosphamide and total body irradiation regimens with autologous bone marrow rescue. (1987) (23)
Antigenic analysis of hematopoiesis: II. Expression of human neutrophil antigens on normal and leukemic marrow cells. (1984) (23)
Investigation of the role of interleukin-6 and hepcidin antimicrobial peptide in the development of anemia with age (2013) (22)
Stability of patient-specific features of altered DNA replication timing in xenografts of primary human acute lymphoblastic leukemia. (2017) (22)
Intensive alternating drug pairs for treatment of high‐risk childhood acute lymphoblastic leukemia. A pediatric oncology group pilot study (1993) (22)
How Many Human Embryonic Stem Cell Lines Are Sufficient? A U.S. Perspective (2006) (21)
Regulation of cancer stem cell properties by SIX1, a member of the PAX-SIX-EYA-DACH network. (2019) (21)
Ex vivo zidovudine (AZT) treatment of CD34+ bone marrow progenitors causes decreased steady state mitochondrial DNA (mtDNA) and increased lactate production (2004) (20)
CBFβ-SMMHC slows proliferation of primary murine and human myeloid progenitors (2005) (20)
Human Hematopoietic Stem/Progenitor Cells Generate CD5+ B Lymphoid Cells in NOD/SCID Mice (1999) (19)
Coordinate glycosylation and cell surface expression of glycophorin A during normal human erythropoiesis. (1987) (18)
A human-murine chimera model for in utero human hematopoietic stem cell transplantation. (1999) (18)
STAT5 inhibition induces TRAIL/DR4 dependent apoptosis in peripheral T-cell lymphoma (2018) (18)
Antigenic analysis of hematopoiesis. IV. The My-11 hematopoietic cell surface antigen is expressed by myelomonocytic and lymphoid, but not erythroid, progenitor cells. (1986) (18)
Purification and Expansion of Human Hematopoietic Stem/Progenitor Cells (1995) (17)
A Fluidic Culture Platform for Spatially Patterned Cell Growth, Differentiation, and Cocultures. (2018) (17)
Deterministic Lateral Displacement: The Next-Generation CAR T-Cell Processing? (2018) (17)
Comparisons of alloreactive potential of clinical hematopoietic grafts. (1999) (17)
Identification of miR-145 targets through an integrated omics analysis. (2015) (17)
Large scale separation of human bone marrow by counterflow centrifugation elutriation. (1986) (17)
Identification and positive selection of human progenitor/stem cells for bone marrow transplantation. (1992) (16)
MIM REGULATES THE TRAFFICKING OF BONE MARROW CELLS VIA MODULATING SURFACE EXPRESSION OF CXCR4 (2016) (16)
1041. Ex Vivo Soluble Fas Ligand Treatment of Donor Cells to Selectively Reduce Murine Acute Graft Versus Host Disease (2006) (16)
High-efficiency stable gene transduction in primary human melanocytes using a lentiviral expression system. (2004) (15)
Expression of hematopoietic progenitor cell associated antigen CD34 in chronic myeloid leukemia. (1991) (14)
Ex Vivo Soluble Fas Ligand Treatment of Donor Cells to Selectively Reduce Murine Acute Graft Versus Host Disease (2006) (14)
AN ANALYSIS OF IMMUNOLOGICAL PHENOTYPES OF HISTIOCYTOSIS-X CELL - A FEASABILITY STUDY FOR PEDIATRIC ONCOLOGY GROUP (1986) (14)
CBFbeta-SMMHC, expressed in M4eo acute myeloid leukemia, reduces p53 induction and slows apoptosis in hematopoietic cells exposed to DNA-damaging agents. (1998) (14)
Intensive timed sequential remission induction chemotherapy with high-dose cytarabine for childhood acute myeloid leukemia. (2001) (13)
Analysis of histiocytosis X infiltrates with monoclonal antibodies directed against cells of histiocytic, lymphoid, and myeloid lineage. (1986) (13)
Translational Research: Toward Better Characterization of Human Embryonic Stem Cell Lines (2005) (13)
Sialylated glycolipid antigens on human leukemic cell lines. (1986) (13)
Reference: CD Antigens 20021 (2002) (11)
Treatment of recurrent and refractory pediatric solid tumors with high-dose busulfan and cyclophosphamide followed by autologous bone marrow rescue. (1992) (11)
Venetoclax and pegcrisantaspase for complex karyotype acute myeloid leukemia (2020) (11)
Leukemia Stem Cells (LSCs) Are Frequent in Childhood Precursor B Acute Lymphoblastic Leukemia (ALL). (2008) (10)
Therapy of childhood acute nonlymphocytic leukemia: the Pediatric Oncology Group experience (1977-1988). (1990) (10)
Cloning of murine hybridoma cells in ultra-low gelation temperature agarose. (1986) (9)
Uncovering low-dimensional, miR-based signatures of acute myeloid and lymphoblastic leukemias with a machine-learning-driven network approach. (2014) (9)
c-Myc overcomes cell cycle inhibition by CBFbeta-SMMHC, a myeloid leukemia oncoprotein. (2002) (9)
TAGmapper: a web-based tool for mapping SAGE tags. (2005) (9)
Profiling tumor counterattack: do Fas ligand-containing microvesicles reduce anticancer immunity? (2005) (9)
Identification of a region on the outer surface of the CBFβ-SMMHC myeloid oncoprotein assembly competence domain critical for multimerization (2006) (9)
Carbohydrate-specific monoclonal antibodies bind to human granulocytes and stimulate antibody-dependent cellular cytotoxicity. (1989) (8)
Correlated miR-mRNA Expression Signatures of Mouse Hematopoietic Stem and Progenitor Cell Subsets Predict “Stemness” and “Myeloid” Interaction Networks (2014) (8)
FLT3-ITD Knock-in Impairs Hematopoietic Stem Cell Quiescence/Homeostasis, Leading to a Myeloproliferative Neoplasm (2011) (8)
CD34 stem cell stories and lessons from the CD34 wars: the Landsteiner Lecture 2009 (2010) (8)
Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax. (2021) (7)
ACharacterize the Major Types of Hematological Malignancies 1 (2006) (7)
Characterization of Erythroid, Lymphoid and Monomyeloid Lineages in Normal Human Bone Marrow (1992) (7)
Stem Cells 20th Anniversary (2002) (7)
A simple high-throughput technology enables gain-of-function screening of human microRNAs. (2013) (7)
Reducing the cost of the cure in childhood leukemia. (1989) (7)
The role of hematopoietic growth factors and oncogenes in leukemogenesis. (1989) (6)
The impact of early intensive therapy on event-free survival (EFS) in children with acute myeloid leukemia (AML). (1992) (6)
Flow cytometric identification of intracellular antigens: detection of minimal residual leukemia. (1990) (6)
Isolation and characterization of the CD34+ hematopoietic progenitor cells from the peripheral blood of patients with chronic myeloid leukemia. (1991) (6)
A Randomized Comparative Study of Purged Autologous Bone Marrow Transplantation Versus Intensive Multiagent Consolidation Chemotherapy in First Remission of Acute Myeloid Leukemia in Children (Pediatric Oncology Group Study—POG 8821) (1997) (6)
Acute myelofibrosis in a child. (1983) (6)
MiR-144 and MiR-451 Regulate Human Erythropoiesis By Targeting RAB14 (2013) (6)
The PAX-SIX-EYA-DACH network modulates GATA-FOG function in fly hematopoiesis and human erythropoiesis (2019) (6)
345. Hematopoietic Stem-Progenitor Cells Express CD52 mRNA and Membrane Protein (2006) (6)
Levels of p 53 Protein Increase with Maturation in Human Hematopoietic Cells 1 (2006) (6)
Rapid separation of whole human bone marrow aspirates by counterflow centrifugation elutriation. (1987) (5)
Summary Notch inhibits Ptf 1 function and acinar cell differentiation in developing mouse and zebrafish pancreas (5)
CBF (cid:98) -SMMHC, Expressed in M4eo Acute Myeloid Leukemia, Reduces p53 Induction and Slows Apoptosis in Hematopoietic Cells Exposed to DNA-Damaging Agents (1998) (5)
Hematopoietic differentiation of human embryonic stem cells progresses through sequential hemato-endothelial, primitive, and definitive stages resembling human yolk sac development Short Title: A Model for Human Embryonic Hematopoiesis (2005) (5)
Specific binding of erythropoietin to human erythroid colony-forming cells. (1987) (5)
Cord blood transplantation: a promising future. (1997) (5)
DNA Demethylating Agents Generate a Brcaness Effect in Multiple Sporadic Tumor Types: Prediction for Sensitivity to PARP Inhibitors in AML (2017) (5)
Commitment to Biomedical Research…Clearing Unnecessary Impediments to Progress (2002) (5)
Inferring MicroRNA Regulation of mRNA with Partially Ordered Samples of Paired Expression Data and Exogenous Prediction Algorithms (2012) (5)
Initiation in DNA synthesis by colony-stimulating factors in subsets of human CD34+ marrow cells. (1991) (4)
CD34+ progenitor/stem cells for transplantation (1994) (4)
Stem Cell Research: Back to the Future (2001) (4)
CD34 antigen expression of acute myeloid leukemia‐colony forming cells (1992) (4)
Granulomatous Disease Cells from Patients with X-linked Chronic + Mobilized CD 34 Oxidase Defect in NOD / SCID Mouse Repopulating Peripheral Blood Lentivector Corrects thephox Generation Self-Inactivating gp 91 rd (2002) (4)
Cloned Photomicrographs, Not Cloned Cells (2007) (4)
CD Antigens 2001 (2002) (3)
Purified progenitor/The International Journal of Cell Cloning: Background, feasibility, and prospects for clinical transplantation (1992) (3)
QT interval prolongation and cardiac dysrhythmia in a patient receiving amsacrine. (1984) (3)
Comparative efficacy and mechanism of action of cardiac progenitor cells after cardiac injury (2022) (3)
Hypoxia-inducible factor 1-alpha enhances the secretome to rejuvenate adult cardiosphere-derived cells. (2021) (3)
CD antigens 2001 (2001) (3)
Ex vivo expansion of mafosfamide-purged PBPC products. (2006) (3)
Hematopoietic Cell Transplantation for Pediatric Patients With Solid Tumors (2007) (3)
Gene Therapy in Clinical Applications: OVERVIEW: How Do We Translate Gene Therapy to Clinical Trials? (2000) (3)
348. Kruppel-Like Factor 4 Regulates Proliferation of Human and Mouse Hematopoietic Stem-Progenitor Cells, but Is Not Essential for Mouse Hematopoietic Repopulation (2006) (3)
Efficacy and toxicity of methanesulfon-m-anisidine, 4'-(9-acridinylamino) 24992) (m-AMSA) in advanced childhood leukemia (1981) (2)
Optimized culture medium for enhanced ex vivo expansion of human hematopoietic stem cells (2019) (2)
Markers in Human Lymphoid Tumors (1980) (2)
Immunodiagnosis of acute nonlymphocytic leukemia. (1990) (2)
CD antigens 2001 (2001) (2)
The Mir-23a∼Mir-27a∼Mir-24 Cluster Acts as a Tumor Suppressor In Leukemias by Post-Transcriptional Regulation of 14-3-3 Proteins (2010) (2)
Integrated analysis of CRLF2 signaling in acute lymphoblastic leukemia identifies Polo-like kinase 1 as a potential therapeutic target (2015) (2)
MicroRNA hsa-mir-16 Contributes to Regulation of Myeloid Differentiation of Human CD34+ Cells. (2006) (2)
Stem Cells Journal: Robust growth in 2005 (2006) (2)
Corrigendum to “Interleukin-6 Directly Impairs the Erythroid Development of Human TF-1 Erythroleukemic Cells” [Blood Cells Mol. Dis. 52 (2) (2014)] (2014) (2)
Pediatric oncology group phase II trial of amsacrine in children with solid tumors. (1985) (2)
Young Turks Forum—for the Young and Young at Heart (2000) (2)
The Clinical Outcome of Patients With Acute Myeloid Leukemia Expressing FLT3 Internal Tandem Duplication Mutations Could Be Altered by Treatment Regimen (2003) (2)
Advancing the Fast‐Paced Field Of Stem Cell Research: Stem Cells Increases from 6 to 10 Issues in Its 23rd Year of Publication (2005) (2)
MicroRNA hsa-mir-155 Blocks Myeloid and Erythroid Differentiation of Human CD34+ Cells. (2006) (2)
Human Pluripotent Stem Cells: Science Fiction Poses No Immediate Dangers (2000) (2)
Human cord blood (CB) CD34+ cells are resistant to fas ligand (FasL) (2000) (1)
KLF4 as a Mediator of Quiescence in Hematopoietic Stem/Progenitor Cells. (2004) (1)
Early Intensive Chemotherapy for Children with Acute Myelogenous Leukemia: The Pediatric Oncology Group Experience (1981–1991) (1994) (1)
Mutations which accelerate gl cooperate with cbfβsmmhc to induce acute leukemia in mice (2000) (1)
CD Antigens 2001. (2000) (1)
A Novel 2-Carbon-Linked Dimeric Artemisinin With Potent Antileukemic Activity and Favorable Pharmacology (2022) (1)
Gene Expression and Mutation Analysis (GEMA) –Guided Precision Medicine Targeting PARP1 to Induce Synthetic Lethality in DNA-PK –Deficient Quiescent and BRCA-Deficient Proliferating Leukemia Stem and Progenitor Cells (2014) (1)
CD antigens 2001. (2001) (1)
3′-azido-2′3′-dideoxythymidine (AZT) inhibits proliferation of normal bone marrow progenitor cells by reducing mitochondrial biogenesis (1991) (1)
Deterministic Cell Separation Recovers >2-Fold T Cells, and More Naïve T Cells, for Autologous Cell Therapy As Compared to Centrifugally Prepared Cells (2021) (1)
CD antigens 2001. (2001) (1)
Uncovering Differential Multi-microRNA Signatures of Acute Myeloid and Lymphoblastic Leukemias with a Machine-Learning-Based Network Approach (2014) (1)
Editors' Note for 2004 (2004) (1)
Hematopoietic Stem Cells Identify Known and Novel Transcripts Overexpressed in Microarray and Serial Analysis of Gene Expression Analyses (2004) (1)
Inefficient megakaryopoiesis in mouse hematopoietic stem-progenitor cells lacking T-bet. (2016) (1)
RAB14 and RAB5 Gtpases Regulate Human Erythropoiesis, Potentially Via Opposing Roles in Endosomal Recycling (2015) (1)
Abstract 2023: Artemisinins enhanced the antileukemic efficacy of BCL2 inhibitors (2017) (1)
Sorafenib Treatment Reverses Depletion of Primitive Hematopoietic Stem Cells and Resolves FLT3-ITD Driven Myeloproliferative Disease In a Mouse Model. (2010) (1)
The Hematopoietic Stem Cell (HSC) Compartment in Tristetraprolin (TTP) Knock-out Mice Is Abnormal Phenotypically but Normal Functionally. (2009) (1)
Toxicity evaluation of dihydroxyanthracenedione (DHAD) in combination with cytosine arabinoside (Ara-C) (1987) (1)
SIX1 Transcription Factor Enhances Human Erythropoiesis Via GATA1 (2019) (1)
Abstract 818: Repurposing Artemisinins for treatment of acute leukemias (2014) (1)
Elimination of clonogenic malignant human T cells using monoclonal antibodies in combination with 2'-deoxycoformycin. (1987) (1)
Use of Multi-Omics Approach to Produce a Robust Serum-Free Media for the Expansion of T Cells (2019) (0)
Integrated Analysis Of CRLF2 Signaling In Acute Lymphoblastic Leukemia Identifies Polo-Like Kinase 1 As a Therapeutic Target (2013) (0)
Deterministic lateral displacement in the preparation of cells and compositions for therapeutic uses (2017) (0)
342. RUNX1 Increases Proliferation of Embryoid Bodies Derived from Human Embryonic Stem Cells (2006) (0)
In Memoriam: Brigid Leventhal (1994) (0)
Determination of the Maximum Tolerated Dose of Cyclophosphamide in Conjunction with High-Dose Etoposide and Carboplatin Followed by Autologous CD34+ Hematopoietic Rescue in Pediatric Patients with Recurrent/Refractory Solid Tumors. (2006) (0)
Abstract 4788: MiR-509 inhibits human leukemia cell growth (2014) (0)
Room G, 10/16/2000 9: 00 AM - 11: 00 AM (PS) Patient's Understanding of Investigator Conflict of Interest A-1116 (2000) (0)
Editors' note (2002) (0)
Sialylated glycolipid antigen in human leukemia (1985) (0)
Shortened Erythrocyte Life Span and Increased Oxidative Stress In Erythroid Precursors Are Consistent with Normocytic Anemia In Mice with Chronic Inflammation (2010) (0)
m-AMSA [methenesulfon-m-anisidine, 4'-(9-acridinylamino)24992] activity in pediatric solid tumors (1982) (0)
Inhibited Maturation of Ter119+CD71+ Erythroid Precursors in Mice with Chronic Sterile Abscess. (2008) (0)
Identification of New Alloantigen-Reactive CD8+ Cytotoxic and Suppressor T Cell Subpopulations. (2007) (0)
647 Telomerase activity as a potential prognostic marker in Wilms tumor (1996) (0)
Embryonic Erythropoiesis and Definitive Hematopoiesis from Human Embryonic Stem Cells Is Regulated by Cytokines Controlling HSC Growth. (2004) (0)
A Challenge to Solve “Lichtman's Riddles” (2000) (0)
3 Generation Self-Inactivating gp91 Lentivector Corrects the Oxidase Defect in NOD/SCID Mouse Repopulating Peripheral Blood Mobilized CD34 Cells from Patients with X-linked Chronic Granulomatous Disease Running head: Lentivector correction of X-linked CGD Scientific section heading: Gene Therapy (2002) (0)
Stem Cells: Some Good News (2004) (0)
RAB14 Regulates Human Erythropoiesis and Megakaryopoiesis (2016) (0)
directs monocytic commitment of primary myeloid progenitors α C/EBP (2013) (0)
Troublesome Questions (2006) (0)
Abstract 208: miR-34a Regulates the Secretome Production and Functional Potential of Human Cardiac Progenitor Cells by Heat Shock Factor (2018) (0)
The 3-Drug Combination Treatment ART838, ABT199 Plus Sorafenib Is Effective Against AML Xenografts, Possibly Via Cooperative Targeting of MCL1 (2018) (0)
Granulomatous Disease Mobilized CD34+ Cells from Patients with X-linked Chronic Oxidase Defect in NOD/SCID Mouse Repopulating Peripheral Blood 3rd Generation Self-Inactivating gp91phox Lentivector Corrects the (2013) (0)
FLT3 Internal Tandem Duplication (ITD) Mutations Disrupt Homeostasis in Hematopoietic Stem Cells. (2009) (0)
Hematopoietic Stem Cells (2012) (0)
Ex Vivo Fas Ligand Treatment Selectively Eliminates T Cells That Mediate GVHD. (2006) (0)
Abstract 3385: Expression of CD22, a late B lymphoid antigen, does not distinguish leukemia stem cells from the bulk population in acute lymphoblastic leukemia cases (2012) (0)
EDITORIAL RETRACTION (2006) (0)
Biochemistry and signaling in stem cells, and vice versa. (2013) (0)
Angiotensin-Converting Enzyme (ACE) Expression Defines the Earliest Primitive and Definitive Lympho-Hematopoietic Progenitors Derived from Human Embryonic Stem Cells. (2006) (0)
Nrf2 Regulates Sensitivity of Leukemias to Artemisinins (2016) (0)
770. Selective Elimination of Alloreactive GVHD-Mediating Donor T Cells by Ex Vivo sFasL Treatment (2006) (0)
Sensitive NOD-scid-IL2γnull (NOG-scid) Assay for Human Precursor B Acute Lymphoblastic Leukemias (ALL). (2007) (0)
Glycolipid Antigen Expression in Human Lung Cancer1 (2006) (0)
Erratum (Retracted article): Cloned photomicrographs, not cloned cells (Stem Cells (2005)) (2006) (0)
Whither Stem Cells? (2004) (0)
Treatment of Advanced Retinoblastoma with Syngeneic Bone Marrow Transplantation (2009) (0)
The wizard of Hox (2005) (0)
Exogenous C/EBPα Favors the Monocytic Commitment and Maturation of Normal Murine Myeloid Progenitors. (2005) (0)
Treatment with Soluble Fas Ligand VivoDisease-Mediating Human T Cells by Ex Selective Reduction of Graft-versus-Host (2009) (0)
Generation of a Common Progenitor Population from Human Embryonic Stem Cells That Gives Rise to Both Embryonic Erythropoiesis and Definitive Hematopoiesis. (2005) (0)
A challenge to solve 'Lichtman's riddles': Editorial (2000) (0)
Interleukin-6 Is a Significant Modifier of the Anemia Associated with Aging in Mice. (2012) (0)
Open Access, Rapid Publishing: No Longer a Thing of the Future (2005) (0)
Mutational Analysis of the CBFβ-SMMHC Assembly Competence Domain Identifies a Surface Critical for Multimerization and Inhibition of RUNX1/AML1. (2005) (0)
Support of human CD34+ cell engraftment in nod/scid mice: Dependence on mode of delivery of human mesenchymal stem cells (2000) (0)
Interleukin-6 Reduces Erythroid Development and Mitochondrial Membrane Potential In Human Erythroleukemic Cells (2013) (0)
MicroRNA Expression and Regulation of Hematopoiesis in CD34+ Cells: A Bioinformatic Circuit Diagram of the Hematopoietic Differentiation Control. (2006) (0)
Stem Cells' Impact Continues Its Ascent (2006) (0)
CBFβ-SMMHC Inhibits G1 to S Progression in Primary Murine and Human Myeloid Progenitors Dependent upon Its AML1-Interaction and Assembly Competence Domains. (2004) (0)
t g of ROR Differentiation of Th17 Cells Independently Kruppel-Like Factor 4 Regulates the Cutting Edge: The Transcription Factor (2010) (0)
Childhood acute lymphoblastic leukemia-Part I: Preface (1990) (0)
The EstrogenReceptorCpG Island Is Methylatedin Most HematopoieticNeoplasms1 (1996) (0)
Enforced RUNX1 Expression Increased the Numbers of CD34+ and CD45+ Cells from Human Embryonic Stem Cell-Derived Embryoid Bodies. (2006) (0)
The role of positive stem cell selection for the treatment of malignant solid tumors (1992) (0)
Abstract 4356: Cytotoxicity of the anti-CD22 immunotoxin HA22 against pediatric acute lymphoblastic leukemia (ALL) (2010) (0)
EDITORIAL RETRACTION (2006) (0)
Human marrow cd34+ and cd34+cd38- cells generate high levels of human hematofoiesis in lmmunodeficient mice (1996) (0)
#457 Feasibility of timed-sequential induction chemotherapy with high-dose Ara-C on day 14 for childhood acute myelogenous leukemia (1999) (0)
Kruppel-Like Factor 4 Upregulates p21 and Downregulates Proliferation of Human and Mouse HSPCs, but Is Not Essential for Mouse HSPC Repopulation. (2006) (0)
MicroRNA Maestros of Hematopoiesis (2010) (0)
#643 Mannose binding protein variant alleles are associated with rheumatic disorders in patients with chronic granulomatous disease (1998) (0)
The YAP Transcriptional Co-Activator Is Not Required for Mouse Hematopoiesis, at Steady State or After 5FU Treatment. (2010) (0)
Protein-tyrosinkinase, jak3 (1995) (0)
Directions for future research in childhood lymphoblastic leukemia. (1990) (0)
Acute leukemia in children. (1990) (0)
Abstract 30: miR34a Affects the Functional Potential of Human Cardiac Progenitor Cells (2017) (0)
sugar sequence in lacto-N-neotetraose Anti-My-28, an antigranulocyte mouse monoclonal antibody, binds to a (2011) (0)
CXCR4 expression does not correlate with engraftment of human myeloid leukemia (AML) samples in NOD/SCID MICE. R (2000) (0)
Hematopoietic Stem Cell Therapy. (2001) (0)
Kruppel-Like Factor 4 Is Essential for Inflammatory Monocyte Differentiation In Vivo 1 (2008) (0)
Stem Cells: 21 Years Old, With the Best Yet to Come (2003) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Curt I. Civin?

Curt I. Civin is affiliated with the following schools: